Jury awards $40M in case alleging Johnson’s Baby Power caused cancer
A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made…
5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now
24/7 Wall St Verizon offers the highest yield at 6.59% with a 0.32 beta and 19 consecutive years…
Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study
Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced…
Johnson & Johnson MedTech U.S. ortho president is leaving
Johnson & Johnson MedTech President of U.S. Orthopaedics Leslie Storms. [Image from LinkedIn]Johnson & Johnson MedTech (NYSE: JNJ)…
Google’s Gemini puts OpenAI on shakier ground, with big market implications
Almost every night, for almost a decade, I got a phone call between 7:00 and 7:01 p.m. ET.…
Stock market today: Live updates
A trader works on the floor of the New York Stock Exchange. NYSE Stock futures were relatively flat…
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…
Trump, RFK Jr. and Texas lawsuits slam Kenvue
Kenvue, the company that makes Tylenol, is fighting on both the political and scientific fronts. The latest blow…
Kimberly-Clark to acquire Kenvue
Trading information on Kenvue Inc., a consumer-health business spun off from Johnson & Johnson, is displayed on a…
J&J lays out plan to splinter orthopedics business into separate company
Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.…